重組蛋白
重組蛋白是解析生物相互作用的關(guān)鍵工具，廣泛應(yīng)用于各類研究實(shí)驗(yàn)中。無(wú)論是商業(yè)化產(chǎn)品，還是為特定研究定制的蛋白，它們都在多種科學(xué)應(yīng)用中發(fā)揮著不可替代的作用。
若您需要優(yōu)質(zhì)重組蛋白——已驗(yàn)證的生物活性、低內(nèi)毒素水平、高純度——來(lái)為您的研究提供可靠支持，這里正是您的理想之選。
歷經(jīng)18年積累，華美生物已構(gòu)建覆蓋原核與真核的五大蛋白質(zhì)表達(dá)系統(tǒng)。我們擁有包括桿狀病毒外膜蛋白（OMP）表達(dá)技術(shù)、膜蛋白表達(dá)技術(shù)等在內(nèi)的多項(xiàng)蛋白表達(dá)與純化專有技術(shù)，致力于為您提供高質(zhì)量的重組蛋白解決方案。
產(chǎn)品特點(diǎn)
- 覆蓋廣泛：擁有超過(guò)16,000種重組蛋白，涵蓋人類、小鼠、大鼠、兔、豚鼠、雞、猴、豬等多種物種的基因與靶點(diǎn)，支持跨物種比較研究。
- 表達(dá)系統(tǒng)全面：提供五大表達(dá)系統(tǒng)，包括大腸桿菌、酵母、桿狀病毒-昆蟲(chóng)細(xì)胞、哺乳動(dòng)物細(xì)胞以及特有的無(wú)細(xì)胞表達(dá)系統(tǒng)。該系統(tǒng)省去質(zhì)粒轉(zhuǎn)化、細(xì)胞培養(yǎng)、破碎離心等步驟，顯著提升蛋白制備效率。
- 多標(biāo)簽選擇：支持His、GST、Flag、MBP等多種標(biāo)簽，便于后續(xù)純化、檢測(cè)與功能研究。
- 多領(lǐng)域應(yīng)用：適用于抗原制備、細(xì)胞與分析、蛋白互作、藥物研發(fā)、酶活性檢測(cè)、ELISA標(biāo)準(zhǔn)品、體內(nèi)外研究、質(zhì)譜與結(jié)構(gòu)分析等廣泛場(chǎng)景。
- 無(wú)動(dòng)物源成分：我們已建立全程無(wú)動(dòng)物副產(chǎn)品接觸的重組蛋白生產(chǎn)線，確保產(chǎn)品的高純凈性與一致性，適用于對(duì)來(lái)源敏感的各類實(shí)驗(yàn)。
重組蛋白目錄
以下是所有重組蛋白的目錄。您可以在目錄中找到適合您研究的蛋白質(zhì)，或在本網(wǎng)站頭部的搜索框中搜索它們。
如果您找不到您需要的重組蛋白，請(qǐng)查看華美生物蛋白定制服務(wù)。
通過(guò)選擇目標(biāo)名稱的首字母瀏覽產(chǎn)品。
| 產(chǎn)品名稱 | 貨號(hào) | 規(guī)格 |
|---|---|---|
| Recombinant Neosartorya fumigata Probable 1,4-beta-D-glucan cellobiohydrolase A (cbhA) | CSB-YP703353NGS CSB-EP703353NGS CSB-BP703353NGS CSB-MP703353NGS CSB-EP703353NGS-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Neosartorya fumigata Eukaryotic translation initiation factor 3 subunit J (hcr1) | CSB-YP703354NGS CSB-EP703354NGS CSB-BP703354NGS CSB-MP703354NGS CSB-EP703354NGS-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Neosartorya fumigata Protein transport protein sec13 (sec13) | CSB-YP703355NGS CSB-EP703355NGS CSB-BP703355NGS CSB-MP703355NGS CSB-EP703355NGS-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Neosartorya fumigata Tethering factor for nuclear proteasome sts1 (sts1) | CSB-YP703356NGS CSB-EP703356NGS CSB-BP703356NGS CSB-MP703356NGS CSB-EP703356NGS-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Neosartorya fumigata Chromatin modification-related protein eaf1 (eaf1), partial | CSB-YP703357NGS CSB-EP703357NGS CSB-BP703357NGS CSB-MP703357NGS CSB-EP703357NGS-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Neosartorya fumigata Altered inheritance of mitochondria protein 31, mitochondrial (aim31), partial | CSB-YP703358NGS1 CSB-EP703358NGS1 CSB-BP703358NGS1 CSB-MP703358NGS1 CSB-EP703358NGS1-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Neosartorya fumigata Probable ubiquitination network signaling protein acrB (acrB), partial | CSB-YP703359NGS CSB-EP703359NGS CSB-BP703359NGS CSB-MP703359NGS CSB-EP703359NGS-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Neosartorya fumigata Endoplasmic reticulum vesicle protein 25 (erv25), partial | CSB-YP703360NGS CSB-EP703360NGS CSB-BP703360NGS CSB-MP703360NGS CSB-EP703360NGS-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Neosartorya fumigata Probable endopolygalacturonase A (pgaA) | CSB-YP703361NGS CSB-EP703361NGS CSB-BP703361NGS CSB-MP703361NGS CSB-EP703361NGS-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Neosartorya fumigata Mannitol 2-dehydrogenase (AFUA_4G14450), partial | CSB-YP703362NGS CSB-EP703362NGS CSB-BP703362NGS CSB-MP703362NGS CSB-EP703362NGS-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Neosartorya fumigata Translationally-controlled tumor protein homolog (AFUA_1G16840) | CSB-YP703363NGS CSB-EP703363NGS CSB-BP703363NGS CSB-MP703363NGS CSB-EP703363NGS-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Neosartorya fumigata tRNA-dihydrouridine (47) synthase [NAD (P) (+)] (dus3), partial | CSB-YP703364NGS CSB-EP703364NGS CSB-BP703364NGS CSB-MP703364NGS CSB-EP703364NGS-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Neosartorya fumigata AP-2 complex subunit sigma (aps2) | CSB-YP703365NGS CSB-EP703365NGS CSB-BP703365NGS CSB-MP703365NGS CSB-EP703365NGS-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Neosartorya fumigata Mitogen-activated protein kinase hog1 (hog1) | CSB-YP703366NGS CSB-EP703366NGS CSB-BP703366NGS CSB-MP703366NGS CSB-EP703366NGS-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Neosartorya fumigata Pre-mRNA-splicing factor clf1 (clf1), partial | CSB-YP703367NGS CSB-EP703367NGS CSB-BP703367NGS CSB-MP703367NGS CSB-EP703367NGS-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Neosartorya fumigata Probable E3 ubiquitin-protein ligase hulA (hulA), partial | CSB-YP703368NGS CSB-EP703368NGS CSB-BP703368NGS CSB-MP703368NGS CSB-EP703368NGS-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Neosartorya fumigata Serine/threonine-protein kinase bur1 (bur1), partial | CSB-YP703369NGS CSB-EP703369NGS CSB-BP703369NGS CSB-MP703369NGS CSB-EP703369NGS-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Neosartorya fumigata Histone-lysine N-methyltransferase, H3 lysine-36 specific (set2), partial | CSB-YP703370NGS CSB-EP703370NGS CSB-BP703370NGS CSB-MP703370NGS CSB-EP703370NGS-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Neosartorya fumigata Pre-mRNA-splicing factor cwc2 (cwc2) | CSB-YP703371NGS CSB-EP703371NGS CSB-BP703371NGS CSB-MP703371NGS CSB-EP703371NGS-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Neosartorya fumigata Probable Xaa-Pro aminopeptidase P (ampp), partial | CSB-YP703372NGS CSB-EP703372NGS CSB-BP703372NGS CSB-MP703372NGS CSB-EP703372NGS-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
有用資源
什么是重組蛋白?
重組蛋白是一種可操縱的蛋白質(zhì)形式，可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中，除了表達(dá)系統(tǒng)之外，還面臨著一系列令人困惑的選擇，如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí)，你必須做出很多決定。如果你選擇的明智，你將獲得高質(zhì)量的重組蛋白，后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定，你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里，來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示，可以幫助你做出明智的決策。
第一條：重組蛋白的生產(chǎn)，在這篇文章中，我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。
第二條：如何選擇合適的表達(dá)載體?
表達(dá)載體是一種DNA分子，它攜帶特定的基因進(jìn)入宿主細(xì)胞，并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá)，經(jīng)過(guò)多年的發(fā)展，表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示，本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。
根據(jù)重組蛋白的不同應(yīng)用，對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題，并提供一些解決方案。除了以上文章，我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://www.practicalworld.cn/technology-91.html。此外，我們還為我們的客戶提供重組蛋白表達(dá)服務(wù)，您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn)，涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等，您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。
引用資料
Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023
Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023
Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023
Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023
Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022
